Publication Category: Basic Science
Antioxidant system response is modified by dietary fat in adipose tissue of metabolic syndrome patients
- P. Peña-Orihuela; A. Camargo; O. A. Rangel-Zuñiga; P. Perez-Martinez; C. Cruz-Teno; J. Delgado-Lista; E. M. Yubero-Serrano; J. A. Paniagua; F. J. Tinahones; M. M. Malagon; H. M. Roche; F. Perez-Jimenez; J. Lopez-Miranda Antioxidant system response is modified by dietary fat in adipose tissue of metabolic syndrome patients Journal of Nutritional Biochemistry
Insulin receptor substrate-2 gene variants in subjects with metabolic syndrome: Association with plasma monounsaturated and n-3 polyunsaturated fatty acid levels and insulin resistance
- P. Perez-Martinez; J. Delgado-Lista; A. Garcia-Rios; A. C. Tierney; H. L. Gulseth; C. M. Williams; B. Karlström; B. Kieć-Wilk; E. E. Blaak; O. Helal; W. H. M. Saris; C. Defoort; C. A. Drevon; J. A. Lovegrove; A. Dembinska-Kieć; U. Riserus; H. M. Roche; J. Insulin receptor substrate-2 gene variants in subjects with metabolic syndrome: Association with plasma monounsaturated and n-3 polyunsaturated fatty acid levels and insulin resistance Molecular Nutrition and Food Research
Gut microbiome of a porcine model of metabolic syndrome and HF-pEF
- A. N. O'Donovan; F. M. Herisson; F. Fouhy; P. M. Ryan; D. Whelan; C. N. Johnson; G. Cluzel; R. P. Ross; C. Stanton; N. M. Caplice Gut microbiome of a porcine model of metabolic syndrome and HF-pEF Am J Physiol Heart Circ Physiol
miR-758-3p: a blood-based biomarker that’s influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome
- S. O'Neill; M. B. Larsen; S. Gregersen; K. Hermansen; L. O'Driscoll miR-758-3p: a blood-based biomarker that’s influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome Oncotarget
Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial
- B. V. Loughrey; A. McGinty; I. S. Young; D. R. McCance; L. A. Powell Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial Clinical endocrinology
Pathophysiology of the metabolic syndrome
- E. McCracken; M. Monaghan; S. Sreenivasan Pathophysiology of the metabolic syndrome Clin Dermatol
Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome
- J. Lopez-Moreno; G. M. Quintana-Navarro; A. Camargo; R. Jimenez-Lucena; J. Delgado-Lista; C. Marin; F. J. Tinahones; G. E. Striker; H. M. Roche; P. Perez-Martinez; J. Lopez-Miranda; E. M. Yubero-Serrano Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome Mol Nutr Food Res
Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice
- K. Kaliannan; R. C. Robertson; K. Murphy; C. Stanton; C. Kang; B. Wang; L. Hao; A. K. Bhan; J. X. Kang Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice Microbiome
Influence of endothelial dysfunction on telomere length in subjects with metabolic syndrome: LIPGENE study
- L. González-Guardia; E. M. Yubero-Serrano; O. Rangel-Zuñiga; C. Marin; A. Camargo; P. Pérez-Martínez; J. Delgado-Lista; F. Gómez-Delgado; A. Garcia-Rios; F. J. Tinahones; H. M. Roche; F. Pérez-Jiménez; J. López-Miranda Influence of endothelial dysfunction on telomere length in subjects with metabolic syndrome: LIPGENE study Age